https://www.selleckchem.com/pr....oducts/lenalidomide-
Activation of Poly (ADP-ribose) polymerase 1 (PARP1), a post-translational modifying enzyme, has been shown to be involved with several inflammatory and viral diseases. The goal of this review is to highlight the mechanisms underlying PARP1 activation during viral or infectious pathogenesis and to assess potential possibilities of using PARP1 inhibitors as a therapeutic countering of SARS-CoV-2 virus. An extensive bibliographic search was done using Pubmed, Mendeley and google scholar with key words. Pre-prints are reported w
Like
Comment
Share
